BUFFALO, N.Y. — On Wednesday, ECMC announced the establishment of a community COVID-19 testing program, which will create 27 new testing sites throughout three Western New York counties.
The 27 sites will be run by 10 community health centers and primary care practice organizations throughout Erie, Niagara and Chautauqua counties. The community health centers and primary care practice organizations have been approved to receive $2.3 million in Delivery Service Reform Incentive Program (DSRIP) funds. The testing sites have been made possible through ECMC by redirecting Medicaid funds.
The testing sites and three mobile units will be placed in 17 zip codes that have been hit the hardest by the pandemic. This includes Amherst, Buffalo, Dunkirk, Jamestown, Lockport, Niagara Falls, North Tonawanda, Wheatfield and Williamsville.
“The ECMC DSRIP-funded community testing sites program is part of a multi-pronged community-based healthcare initiative designed to support Western New York’s vulnerable, at-risk residents during the COVID-19 pandemic," said Thomas J. Quatroche Jr. Ph.D., president and CEO of ECMC. "NYS Medicaid Waiver funding is being used in these vulnerable communities to increase testing and link individuals with primary care. The COVID-19 pandemic is disproportionately affecting minority and economically challenged areas due to social determinants of health that have created underlining health conditions in these communities.”
The full list of testing sites can be found below.
All sites open Monday through Friday from 3 p.m to 5 p.m.
June is LGBTQ+ Pride month. We're celebrating key moments in LGBTQ+ history in a new series called "60 Seconds of Pride." 60 seconds of Pride: LGBTQ fight for rights began with a secret society formed in 1950 What began as a moment that sparked the fight for LGBTQ+ equality in the 1960s became a movement […]
By RICARDO ALONSO-ZALDIVA WASHINGTON (AP) — Democrats are committed to passing legislation this year to curb prescription drug prices, but they’re still disagreeing on how to cut costs for patients and taxpayers while preserving profits that lure investors to back potentially promising treatments. It boils down to finding a balance: How big a stick should […]